| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-06 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.23 | 6e-05 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |